Pamidronate in chronic non-bacterial osteomyelitis: a randomized, double-blinded, placebo-controlled pilot trial

References

• Ferguson PJ, El-Shanti HI. Autoinflammatory bone disorders. Curr Opin Rheumatol 2007;19:492–8.
   PubMed Web of Science ®Google Scholar
• Vittecoq O, Said LA, Michot C, Mejjad O, Thomine JM, Mitrofanoff P, et al. Evolution of chronic recurrent multifocal osteitis toward spondylarthropathy over the long term. Arthritis Rheum 2000;43:109–19.
   PubMed Web of Science ®Google Scholar
• Benhamou CL, Chamot AM, Kahn MF. Synovitis-acne-pustulosis hyperostosis-osteomyelitis syndrome (SAPHO). A new syndrome among the spondyloarthropathies? Clin Exp Rheumatol 1988;6:109–12.
   PubMed Web of Science ®Google Scholar
• Jansson A, Renner ED, Ramser J, Mayer A, Haban M, Meindl A, et al. Classification of non-bacterial osteitis: retrospective study of clinical, immunological and genetic aspects in 89 patients. Rheumatology (Oxford) 2007;46:154–60.
   PubMed Web of Science ®Google Scholar
• Hayem G. Valuable lessons from SAPHO syndrome. Joint Bone Spine 2007;74:123–6.
   PubMed Web of Science ®Google Scholar
• Orphanet. The portal for rare diseases and orphan drugs (www.orpha.net). Accessed 29 January 2020.
   Google Scholar
• Colina M, Govoni M, Orzincolo C, Trotta F. Clinical and radiologic evolution of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a single center study of a cohort of 71 subjects. Arthritis Rheum 2009;15:813–21.
   Web of Science ®Google Scholar
• Leone A, Cassar-Pullicino VN, Casale R, Magarelli N, Semprini A, Colosimo C. The SAPHO syndrome revisited with an emphasis on spinal manifestations. Skeletal Radiol 2015;44:9–24.
   PubMed Web of Science ®Google Scholar
• Jurik AG, Klicman RF, Simoni P, Robinson P, Teh J. SAPHO and CRMO: the value of imaging. Semin Musculoskelet Radiol 2018;22:207–24.
   PubMed Web of Science ®Google Scholar
• Probst FP, Björksten B, Gustavson KH. Radiological aspect of chronic recurrent multifocal osteomyelitis. Ann Radiol (Paris) 1978;21:115–25.
   PubMedGoogle Scholar
• Østergaard M, Eshed I, Althoff CE, Poggenborg RP, Diekhoff T, Krabbe S, et al. Whole-body magnetic resonance imaging in inflammatory arthritis: systematic literature review and first steps toward standardization and an omeract scoring system. J Rheumatol 2017;44:1699–705.
   PubMed Web of Science ®Google Scholar
• Andreasen CM, Jurik AG, Glerup M, Høs C, Mahler B, Hauge EM, et al. Response to early-onset pamidronate treatment in chronic non-bacterial osteomyelitis: a retrospective single center study. J Rheumatol 2019;46:1515–23.
   PubMed Web of Science ®Google Scholar
• Weckbach S. Whole-body MRI for inflammatory arthritis and other multifocal rheumatoid diseases. Semin Musculoskelet Radiol 2012;16:377–88.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Wu EY, Oliver MS, Cooper AM, Basiaga ML, Vora SS, et al. Consensus treatment plans for chronic nonbacterial osteomyelitis refractory to nonsteroidal antiinflammatory drugs and/or with active spinal lesions. Arthritis Care Res (Hoboken) 2018;70:1228–37.
   PubMed Web of Science ®Google Scholar
• Delattre E, Guillot X, Godfrin-Valnet M, Prati C, Wendling D. SAPHO syndrome treatment with intravenous pamidronate. Retrospective study of 22 patients. Joint Bone Spine 2014;81:456–8.
   PubMed Web of Science ®Google Scholar
• Cremers S, Papapoulos S. Pharmacology of bisphosphonates. Bone 2011;49:42–9.
   PubMed Web of Science ®Google Scholar
• Viereck V, Emons G, Lauck V, Frosch K-H, Blaschke S, Gründker C, et al. Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts. Biochem Biophys Res Commun 2002;291:680–6.
   PubMed Web of Science ®Google Scholar
• Maksymowych WP. Bisphosphonates for arthritis-a confusing rationale. J Rheumatol 2003;30:430–4.
   PubMed Web of Science ®Google Scholar
• World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013;310:2191–4.
   PubMed Web of Science ®Google Scholar
• Jansson AF, Müller TH, Gliera L, Ankerst DP, Wintergerst U, Belohradsky BH, et al. Clinical score for nonbacterial osteitis in children and adults. Arthritis Rheum 2009;60:1152–9.
   PubMed Web of Science ®Google Scholar
• Weber U, Lambert RG, Rufibach K, Maksymowych WP, Hodler J, Zejden A, et al. Anterior chest wall inflammation by whole-body magnetic resonance imaging in patients with spondyloarthritis: lack of association between clinical and imaging findings in a cross-sectional study. Arthritis Res Ther 2012;14:R3.
   PubMed Web of Science ®Google Scholar
• Madsen KB, Jurik AG. MRI grading method for active and chronic spinal changes in spondyloarthritis. Clin Radiol 2010;65:6–14.
   PubMed Web of Science ®Google Scholar
• Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137–45.
   PubMed Web of Science ®Google Scholar
• Brooks R. EuroQol: the current state of play. Health Policy 1996;37:53–72.
   PubMed Web of Science ®Google Scholar
• Ware J, Snow K, Kosinski M, Gandek B, eds. SF-36 health survey manual and interpretation guide. Boston, MA: New England Medical Center, The Health Institute, 1993.
   Google Scholar
• Kragstrup TW, Vorup-Jensen T, Deleuran B, Hvid M. A simple set of validation steps identifies and removes false results in a sandwich enzyme-linked immunosorbent assay caused by anti-animal IgG antibodies in plasma from arthritis patients. Springerplus 2013;2:263.
   PubMed Web of Science ®Google Scholar
• Li C, Zhao Y, Zuo Y, Zhou Y, Zhang F, Liu S, et al. Efficacy of bisphosphonates in patients with synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a prospective open study. Clin Exp Rheumatol 2019;37:663–9.
   PubMed Web of Science ®Google Scholar
• Lukas C, Braun J, van der Heijde D, Hermann K-GA, Rudwaleit M, Ostergaard M, et al. Scoring inflammatory activity of the spine by magnetic resonance imaging in ankylosing spondylitis: a multireader experiment. J Rheumatol 2007;34:862–70.
   PubMed Web of Science ®Google Scholar
• Miettunen PMH, Wei X, Kaura D, Reslan WA, Aguirre AN, Kellner JD. Dramatic pain relief and resolution of bone inflammation following pamidronate in 9 pediatric patients with persistent chronic recurrent multifocal osteomyelitis (CRMO). Pediatr Rheumatol 2009;7:1–14.
   PubMed Web of Science ®Google Scholar
• Hofmann C, Wurm M, Schwarz T, Neubauer H, Beer M, Girschick H, et al. A standardized clinical and radiological follow-up of patients with chronic non-bacterial osteomyelitis treated with pamidronate. Clin Exp Rheumatol 2014;32:604–9.
   PubMed Web of Science ®Google Scholar
• Roderick M, Shah R, Finn A, Ramanan AV. Efficacy of pamidronate therapy in children with chronic non-bacterial osteitis: disease activity assessment by whole body magnetic resonance imaging. Rheumatology (Oxford) 2014;53:1973–6.
   PubMed Web of Science ®Google Scholar
• Hospach T, Langendoerfer M, von Kalle T, Maier J, Dannecker GE. Spinal involvement in chronic recurrent multifocal osteomyelitis (CRMO) in childhood and effect of pamidronate. Eur J Pediatr 2010;169:1105–11.
   PubMed Web of Science ®Google Scholar
• Schnabel A, Range U, Hahn G, Berner R, Hedrich CM. Treatment response and longterm outcomes in children with chronic nonbacterial osteomyelitis. J Rheumatol 2017;44:1058–65.
   PubMed Web of Science ®Google Scholar
• Witt M, Meier J, Hammitzsch A, Proft F, Schulze-Koops H, Grunke M. Disease burden, disease manifestations and current treatment regimen of the SAPHO syndrome in Germany: results from a nationwide patient survey. Semin Arthritis Rheum 2014;43:745–50.
   PubMed Web of Science ®Google Scholar
• Solau-Gervais E, Soubrier M, Gerot I, Grange L, Puechal X, Sordet C, et al. The usefulness of bone remodelling markers in predicting the efficacy of pamidronate treatment in SAPHO syndrome. Rheumatology (Oxford) 2006;45:339–42.
   PubMed Web of Science ®Google Scholar
• Colina M, La Corte R, Trotta F. Sustained remission of SAPHO syndrome with pamidronate: a follow-up of fourteen cases and a review of the literature. Clin Exp Rheumatol 2009;27:112–15.
   PubMed Web of Science ®Google Scholar
• Khosla S. Minireview: the OPG/RANKL/RANK system. Endocrinology 2001;142:5050–5.
   PubMed Web of Science ®Google Scholar
• Takayanagi H. Inflammatory bone destruction and osteoimmunology. J Periodontal Res 2005;40:287–93.
   PubMed Web of Science ®Google Scholar
• Mönkkönen J, Taskinen M, Auriola SO, Urtti A. Growth inhibition of macrophage-like and other cell types by liposome-encapsulated, calcium-bound, and free bisphosphonates in vitro. J Drug Target 1994;2:299–308.
   PubMed Web of Science ®Google Scholar
• Adami S, Zamberlan N. Adverse effects of bisphosphonates. A comparative review. Drug Saf 1996;14:158–70.
   PubMed Web of Science ®Google Scholar
• Pennanen N, Lapinjoki S, Urtti A, Mönkkönen J. Effect of liposomal and free bisphosphonates on the IL-1 beta, IL-6 and TNF alpha secretion from RAW 264 cells in vitro. Pharm Res 1995;12:916–22.
   PubMed Web of Science ®Google Scholar
• Laredo J-D, Vuillemin-Bodaghi V, Boutry N, Cotten A, Parlier-Cuau C. SAPHO syndrome: MR appearance of vertebral involvement. Radiology 2007;242:825–31.
   PubMed Web of Science ®Google Scholar
• Hayem G, Bouchaud-Chabot A, Benali K, Roux S, Palazzo E, Silbermann-Hoffman O, et al. SAPHO syndrome: a long-term follow-up study of 120 cases. Semin Arthritis Rheum 1999;29:159–71.
   PubMed Web of Science ®Google Scholar
• Maugars Y, Berthelot JM, Ducloux JM, Prost A. SAPHO syndrome: a followup study of 19 cases with special emphasis on enthesis involvement. J Rheumatol 1995;22:2135–41.
   PubMed Web of Science ®Google Scholar
• Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009;68:777–83.
   PubMed Web of Science ®Google Scholar
• Hermann K-GA, Baraliakos X, van der Heijde DMFM, Jurik AG, Landewe R, Marzo-Ortega H, et al. Descriptions of spinal MRI lesions and definition of a positive MRI of the spine in axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI study group. Ann Rheum Dis 2012;71:1278–88.
   PubMed Web of Science ®Google Scholar
• Weber U, Zhao Z, Rufibach K, Zubler V, Lambert RGW, Chan SM, et al. Diagnostic utility of candidate definitions for demonstrating axial spondyloarthritis on magnetic resonance imaging of the spine. Arthritis Rheumatol 2015;67:924–33.
   PubMed Web of Science ®Google Scholar
• Aljuhani F, Tournadre A, Tatar Z, Couderc M, Mathieu S, Malochet-Guinamand S, et al. The SAPHO syndrome: a single-center study of 41 adult patients. J Rheumatol 2015;42:329–34.
   PubMed Web of Science ®Google Scholar
• Yang L, Grey V. Pediatric reference intervals for bone markers. Clin Biochem 2006;39:561–8.
   PubMed Web of Science ®Google Scholar